The pathophysiology of NAFLD in obesity is intricate and involves the interaction and dysregulation of several mechanisms, such as insulin resistance, cytokine signaling, and alteration of the gut microbiota. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.